EXEL insider ownership: SVP & General Counsel discloses share holdings
Rhea-AI Filing Summary
Exelixis, Inc. officer reports beneficial ownership of company stock. The SVP and General Counsel is shown as beneficially owning 90,441 shares of Exelixis common stock directly, including 80,575 shares that will be issued upon vesting of restricted stock units and performance-based restricted stock units, and 556 shares acquired under the company’s 2000 Employee Stock Purchase Plan. In addition, 5,527 shares are held indirectly through the Exelixis 401(k) Plan as of November 7, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Includes 80,575 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock. Includes 556 shares acquired under the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 7, 2025.
FAQ
What portion of the Exelixis (EXEL) holdings are in RSUs and PSUs for this officer?
The filing states that 80,575 shares of Exelixis common stock will be issued upon vesting of restricted stock units (RSUs) and performance-based restricted stock units (PSUs), and these are included in the reported direct beneficial ownership.
What is the officer’s role and relationship to Exelixis (EXEL)?
The reporting person is identified as an officer of Exelixis, Inc., serving as SVP and General Counsel, and the filing reports this individual’s beneficial ownership of Exelixis common stock.
Does the filing include any derivative securities for the Exelixis (EXEL) officer?
The section for derivative securities is presented, but in the provided content there are no specific derivative securities listed with dates, exercise prices, or share amounts.